Personalisation of therapy for people with type 2 diabetes and cardiovascular disease risk
Feb 14, 2024 - 00:11:56
Radio and PodcastLive Radio & PodcastsHealth
Advances in incretin therapy: dual agonists and beyond With Prof. Filip Knop
This year saw the regulatory approval of the first dual GIP/GLP-1 dual agonist for type 2 diabetes. With several other multi-agonists in development, what does this mean for clinicians caring for people with type 2 diabe...
About This Episode
Advances in incretin therapy: dual agonists and beyond With Prof. Filip Knop is an episode from Diabetes Knowledge into Practice Podcast by Liberum IME. This year saw the regulatory approval of the first dual GIP/GLP-1 dual agonist for type...
Podcast
This episode belongs to Diabetes Knowledge into Practice Podcast.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jul 15, 2022, 00:16:51 long, audio available.
Related Episodes
Continue listening to more episodes from Diabetes Knowledge into Practice Podcast.
Effective strategies for encouraging behaviour change
Feb 14, 2024 - 00:14:28
World Diabetes Day – Overcoming Cultural Obstacles to Personalise Diabetes Care
Dec 19, 2023 - 00:13:24
Congress special: Highlights from EASD 2023
Dec 11, 2023 - 00:14:00
Striving for Balance: Achieving Glycemic, Weight, and Cardiorenal Targets in T2D Care
Sep 28, 2023 - 00:12:06
Highlights from ADA 2023
Sep 12, 2023 - 00:19:45
Conference special: EASD 2022 Highlights With Prof. Apostolos Tsapas
Nov 14, 2022 - 00:18:25
Publication special: Data from the SURPASS program With Prof Carol Wysham
Sep 27, 2022 - 00:13:35